White Paper: The Cost of Quality in the Specialty Pharmaceutical Supply Chain

By Ruediger Lomb |

Quality vs Expenditure: Are you willing to risk it all? 

As R&D focus shifts towards high-precision, low-volume therapies comprising of expensive and sensitive shipments, what are the repercussions of a temperature excursion or delayed delivery? The impact can be broad and far-reaching, resulting in compounded inefficiencies and increased costs throughout the entire pharmaceutical chain, ultimately affecting the patient relying on timely treatment.

Discover how to create a new quality mindset which enables not only a more robust management system, but can add value for your organization and generate better patient outcomes. 

To download your copy, please enter your details in the form below 

COQ promo image


About the Author

Portrait of Ruediger Lomb

Ruediger Lomb

Vice President, Global Quality and Compliance
AmerisourceBergen Global Commercialization Services & Animal Health
As the Vice President, Global Quality and Compliance for World Courier, as well as for Integrated Commercialization Solutions (ICS), Dr. Ruediger Lomb oversees the quality program for both entities, ensuring facility and process compliance with all current and future GxP standards such as relevant FDA guidelines, the most recent EU Good Distribution Practices Guidelines and other relevant quality standards. Dr. Lomb is a licensed pharmacist and holds a Ph.D. in pharmaceutical biochemistry.
View Bio